OCS stock news
This page provides real-time market news, earnings updates, and company announcements related to Oculis Holding AG (OCS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 24:01 EST
Oculis Appoints Katie Kazem as Chief Legal Officer
Finviz2026-02-17 09:03:11
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
Finviz2026-03-03 21:09:41
Oculis Publishes 2025 Consolidated Financial Statements
Finviz2026-03-05 09:03:54
Oculis to Participate in Upcoming Investor Conferences
Finviz2026-03-05 09:03:55
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Finviz2026-03-16 09:03:52
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis
Finviz2026-03-31 08:09:48
Oculis to Participate in Upcoming Investor Conferences
Finviz2026-04-07 08:03:44
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Finviz2026-03-16 09:03:52
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis
Finviz2026-03-31 08:09:48
Oculis to Participate in Upcoming Investor Conferences
Finviz2026-04-07 08:03:44
OCS stock chart
OCS stock detailsOCS stock price change
On the last trading day, OCS stock closed at 27.54 USD, with a price change of -0.22% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more